Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
Objective: To estimate the cost-effectiveness of omalizumab compared with standard of care in the treatment and control of severe persistent asthma, using the outcomes from the Portuguese subpopulation of the eXpeRience registry. Methods: This was a pragmatic cost-effectiveness analysis based on rea...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2021-03-01
|
| Series: | Pulmonology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S253104372030043X |